16 August 2016
By Dr Wendy Winnall - PCFA Research Team
A new therapy called Radium-223 was approved in the USA in 2013, and in Australia in 2014. As for many drugs, without subsidising by the Pharmaceutical Benefits Scheme, availability in Australia remains limited and often expensive. Frustratingly, long negotiations continue between the company selling Radium-223 and the government. Meanwhile many men who may be helped by this drug remain without. Fortunately clinical trials are being performed that can give some patients access to Radium-223 whilst the talks continue.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
